[PHARMA] YoY TTM Result on 31-Mar-2007 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
25-May-2007
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2007
Quarter
31-Mar-2007 [#1]
Profit Trend
QoQ- 4.89%
YoY- -39.57%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 CAGR
Revenue 1,304,640 1,309,712 1,237,398 1,063,349 959,313 836,558 669,384 11.75%
PBT 73,685 83,409 95,042 28,514 32,734 79,358 69,597 0.95%
Tax -17,340 -26,289 -30,835 -13,853 -9,671 -30,208 -28,103 -7.72%
NP 56,345 57,120 64,207 14,661 23,063 49,150 41,494 5.22%
-
NP to SH 54,977 56,008 62,556 13,091 21,662 49,150 41,494 4.79%
-
Tax Rate 23.53% 31.52% 32.44% 48.58% 29.54% 38.07% 40.38% -
Total Cost 1,248,295 1,252,592 1,173,191 1,048,688 936,250 787,408 627,890 12.12%
-
Net Worth 439,675 402,378 367,905 321,111 335,032 257,266 236,797 10.85%
Dividend
31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 CAGR
Div 97,382 48,140 35,295 12,310 14,388 15,245 18,045 32.42%
Div Payout % 177.13% 85.95% 56.42% 94.04% 66.42% 31.02% 43.49% -
Equity
31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 CAGR
Net Worth 439,675 402,378 367,905 321,111 335,032 257,266 236,797 10.85%
NOSH 106,977 107,015 106,949 107,037 107,039 102,089 100,764 1.00%
Ratio Analysis
31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 CAGR
NP Margin 4.32% 4.36% 5.19% 1.38% 2.40% 5.88% 6.20% -
ROE 12.50% 13.92% 17.00% 4.08% 6.47% 19.10% 17.52% -
Per Share
31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 CAGR
RPS 1,219.55 1,223.85 1,157.00 993.44 896.23 819.43 664.30 10.65%
EPS 51.39 52.34 58.49 12.23 20.24 48.14 41.18 3.75%
DPS 91.00 45.00 33.00 11.50 13.44 15.00 18.00 30.99%
NAPS 4.11 3.76 3.44 3.00 3.13 2.52 2.35 9.75%
Adjusted Per Share Value based on latest NOSH - 107,037
31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 CAGR
RPS 90.52 90.87 85.86 73.78 66.56 58.04 46.44 11.76%
EPS 3.81 3.89 4.34 0.91 1.50 3.41 2.88 4.77%
DPS 6.76 3.34 2.45 0.85 1.00 1.06 1.25 32.46%
NAPS 0.3051 0.2792 0.2553 0.2228 0.2325 0.1785 0.1643 10.86%
Price Multiplier on Financial Quarter End Date
31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 CAGR
Date 31/03/10 31/03/09 31/03/08 30/03/07 31/03/06 31/03/05 31/03/04 -
Price 4.27 3.45 2.95 3.55 4.73 4.82 5.50 -
P/RPS 0.35 0.28 0.25 0.36 0.53 0.59 0.83 -13.39%
P/EPS 8.31 6.59 5.04 29.03 23.37 10.01 13.36 -7.60%
EY 12.04 15.17 19.83 3.45 4.28 9.99 7.49 8.22%
DY 21.31 13.04 11.19 3.24 2.84 3.11 3.27 36.65%
P/NAPS 1.04 0.92 0.86 1.18 1.51 1.91 2.34 -12.63%
Price Multiplier on Announcement Date
31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 31/03/04 CAGR
Date 26/05/10 08/05/09 28/05/08 25/05/07 25/05/06 18/05/05 18/05/04 -
Price 4.71 3.82 3.45 3.45 4.53 4.86 4.55 -
P/RPS 0.39 0.31 0.30 0.35 0.51 0.59 0.68 -8.84%
P/EPS 9.16 7.30 5.90 28.21 22.38 10.09 11.05 -3.07%
EY 10.91 13.70 16.95 3.55 4.47 9.91 9.05 3.16%
DY 19.32 11.78 9.57 3.33 2.97 3.09 3.96 30.21%
P/NAPS 1.15 1.02 1.00 1.15 1.45 1.93 1.94 -8.34%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment